Comparative Survival Associated With Use of Targeted vs Nontargeted Therapy in Medicare Patients With Metastatic Renal Cell Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative Survival Associated With Use of Targeted vs Nontargeted Therapy in Medicare Patients With Metastatic Renal Cell Carcinoma

Published:2019-06-14 Issue:6 Volume:2 Page:e195806
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Li Pengxiang¹²,Jahnke Jordan¹,Pettit Amy R.³,Wong Yu-Ning⁴⁵,Doshi Jalpa A.¹²³

Affiliation:

1. Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia

2. Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia

3. Center for Public Health Initiatives, University of Pennsylvania, Philadelphia

4. Fox Chase Cancer Center, Philadelphia, Pennsylvania

5. Now with Janssen Scientific Affairs, Titusville, New Jersey

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

http:///jamanetworkopen/article-pdf/2/6/e195806/17675483/li_2019_oi_190236.pdf

Reference54 articles.

1. Kidney cancer, version 2.2017, NCCN clinical practice guidelines in oncology.;Motzer;J Natl Compr Canc Netw,2017

2. Sorafenib in advanced clear-cell renal-cell carcinoma.;Escudier;N Engl J Med,2007

3. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial.;Escudier;Lancet,2007

4. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.;Motzer;N Engl J Med,2007

5. Nivolumab versus everolimus in advanced renal-cell carcinoma.;Motzer;N Engl J Med,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Best practices and recommendations for grossing and reporting of post-immunotherapy nephrectomy specimens: a single-institution experience of 70 cases;Diagnostic Histopathology;2024-05

2. Smoking Cessation After Diagnosis of Kidney Cancer Is Associated With Reduced Risk of Mortality and Cancer Progression: A Prospective Cohort Study;Journal of Clinical Oncology;2023-05-20

3. Management of Metastatic Renal Cell Carcinoma in a Tertiary Care Hospital;Cureus;2023-02-28

4. Overview of clinical management for older patients with renal cell carcinoma;Japanese Journal of Clinical Oncology;2022-04-10

5. Overall survival for oncology drugs approved for genomic indications;European Journal of Cancer;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3